AB&B Bio-Tech Co. Ltd. JS Appoints New Independent Director and Reshuffles Board Committees

Reuters12-04
AB&B Bio-Tech Co. Ltd. JS Appoints New Independent Director and Reshuffles Board Committees

AB&B Bio-Tech Co. Ltd. JS has announced the resignation of Ms. Li Xiaoqing as an independent non-executive director, chairperson of the Audit Committee, and member of the Remuneration and Appraisal Committee and Nomination Committee. Mr. Li has been nominated as her replacement and will assume the roles of independent non-executive director, chairperson of the Audit Committee, and member of the Remuneration and Appraisal Committee, pending approval at the upcoming general meeting. Additionally, Mr. Yu Jianlin will step down from the Nomination Committee, while Ms. Li Runxiang and Mr. Chen Chengbei will join the committee.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251204-11945285), on December 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment